Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (41-50 of 464) with videos related to

Pageof 47
Sort By:
British Journal of Cancer|February 24, 2023
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?Simon R Lord, Adrian L Harris
Biochemical Society Transactions|November 23, 2011
New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesisChern Ein Oon, Adrian L Harris
The Lancet. Oncology|December 4, 2010
Biomarkers to predict the clinical efficacy of bevacizumab in cancerAdrian M Jubb, Adrian L Harris
EMBO Molecular Medicine|May 8, 2014
VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitorDavid M Favara, Adrian L Harris
Annals of Medicine|October 30, 2004
Hypoxia-inducible factors and hypoxic cell death in tumour physiologyAndrea L Bacon, Adrian L Harris
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Macrophages and the hypoxic tumour microenvironmentHelen J Knowles, Adrian L Harris
Journal of Molecular Medicine (Berlin, Germany)|February 18, 2016
Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapyChristos E Zois, Adrian L Harris
Cancer Research|September 3, 2004
Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasionNaomi Robertson, Christian Potter, Adrian L Harris
British Journal of Cancer|October 21, 2021
Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancerErik Knutsen, Adrian L Harris, Maria Perander
Expert Reviews in Molecular Medicine|August 28, 2009
Targeting the hypoxia-inducible factor (HIF) pathway in cancerEvon Poon, Adrian L Harris, Margaret Ashcroft
Pageof 47

Showing results (41-50 of 464) with videos related to

Sort By:
Pageof 47
British Journal of Cancer|February 24, 2023
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?Simon R Lord, Adrian L Harris
Biochemical Society Transactions|November 23, 2011
New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesisChern Ein Oon, Adrian L Harris
The Lancet. Oncology|December 4, 2010
Biomarkers to predict the clinical efficacy of bevacizumab in cancerAdrian M Jubb, Adrian L Harris
EMBO Molecular Medicine|May 8, 2014
VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitorDavid M Favara, Adrian L Harris
Annals of Medicine|October 30, 2004
Hypoxia-inducible factors and hypoxic cell death in tumour physiologyAndrea L Bacon, Adrian L Harris
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Macrophages and the hypoxic tumour microenvironmentHelen J Knowles, Adrian L Harris
Journal of Molecular Medicine (Berlin, Germany)|February 18, 2016
Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapyChristos E Zois, Adrian L Harris
Cancer Research|September 3, 2004
Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasionNaomi Robertson, Christian Potter, Adrian L Harris
British Journal of Cancer|October 21, 2021
Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancerErik Knutsen, Adrian L Harris, Maria Perander
Expert Reviews in Molecular Medicine|August 28, 2009
Targeting the hypoxia-inducible factor (HIF) pathway in cancerEvon Poon, Adrian L Harris, Margaret Ashcroft
Pageof 47